Clinical Trials
0
Active:0
Completed:0
Trial Phases
0 Phases
Drug Approvals
39
NMPA:39
Drug Approvals
Dextromethorphan Hydrobromide Oral Solution
- Product Name
- 氢溴酸右美沙芬口服液
- Approval Number
- 国药准字H20247008
- Approval Date
- Jan 10, 2024
NMPA
Compound Sodium Chloride Eye Drops
- Product Name
- 复方氯化钠滴眼液
- Approval Number
- 国药准字H20093546
- Approval Date
- Sep 28, 2023
NMPA
Levofloxacin Hydrochloride Injection
- Product Name
- 盐酸左氧氟沙星注射液
- Approval Number
- 国药准字H20084157
- Approval Date
- Feb 16, 2023
NMPA
Naphazoline Hydrochloride Chlorphenamine Maleate and Vitamin B12 Eye Drops
- Product Name
- 萘敏维滴眼液
- Approval Number
- 国药准字H20065901
- Approval Date
- Apr 8, 2021
NMPA
Dihydroergotoxine Methanesulfonate Injection
- Product Name
- 甲磺酸双氢麦角毒碱注射液
- Approval Number
- 国药准字H20067759
- Approval Date
- Apr 8, 2021
NMPA
Bromisovale and Procaine Injection
- Product Name
- 溴米那普鲁卡因注射液
- Approval Number
- 国药准字H13024491
- Approval Date
- Nov 6, 2020
NMPA
- Prev
- 1
- 2
- 3
- 4
- Next
Clinical Trials
No trials found
News
No news found